MedPath

Phenyl salicylate

Generic Name
Phenyl salicylate
Brand Names
Hyophen, Phosphasal, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Ustell, Utira
Drug Type
Small Molecule
Chemical Formula
C13H10O3
CAS Number
118-55-8
Unique Ingredient Identifier
28A37T47QO

Overview

Phenyl salicylate is a 2-hydroxybenzoic acid phenyl ester. It is utilized in some manufacturing processes of polymers, lacquers, adhesives, waxes, as well as polishes. It is an active ingredient in some pharmaceutical products as a mild analgesic for pain relief by releasing salicylate (found in Aspirin ). Phenyl salicylate may also be found in some antiseptic agents . It is synthesized by heating salicylic acid with phenol , . Phenyl salicylate is used as a food additive in the USA . This compound belongs to the class of organic compounds known as depsides and depsidones. These are polycyclic compounds that is either a polyphenolic compound composed of two or more monocyclic aromatic units linked by an ester bond (depside), or a compound containing the depsidone structure (depsidone) .

Background

Phenyl salicylate is a 2-hydroxybenzoic acid phenyl ester. It is utilized in some manufacturing processes of polymers, lacquers, adhesives, waxes, as well as polishes. It is an active ingredient in some pharmaceutical products as a mild analgesic for pain relief by releasing salicylate (found in Aspirin ). Phenyl salicylate may also be found in some antiseptic agents . It is synthesized by heating salicylic acid with phenol , . Phenyl salicylate is used as a food additive in the USA . This compound belongs to the class of organic compounds known as depsides and depsidones. These are polycyclic compounds that is either a polyphenolic compound composed of two or more monocyclic aromatic units linked by an ester bond (depside), or a compound containing the depsidone structure (depsidone) .

Indication

Pain and fever .

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
ORAL
36.2 mg in 1 1
2017/01/05
0076-0901
ORAL
36 mg in 1 1
2017/01/10
0076-0903
ORAL
36 mg in 1 1
2023/12/12
58657-456
ORAL
36.2 mg in 1 1
2024/01/22
0178-0745
ORAL
36 mg in 1 1
2018/05/21
15338-503
ORAL
36.2 mg in 1 1
2014/06/09
54859-701
ORAL
32.4 mg in 1 1
2018/05/21
15338-502
Vilvet Pharmaceuticals Inc
ORAL
36 mg in 1 1
2019/02/21
71186-002
ORAL
36.2 mg in 1 1
2023/07/06
28595-224
ORAL
36 mg in 1 1
2023/11/22
0178-0740

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No HSA products found

No HSA products found for this drug

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath